Simpson J H, Lynch R, Grant J, Alroomi L
Paediatric Department, Princess Royal Maternity Hospital, Glasgow G31 2ER, Scotland, UK.
Arch Dis Child Fetal Neonatal Ed. 2004 Nov;89(6):F480-2. doi: 10.1136/adc.2003.044438.
Medication errors are common in the neonatal intensive care unit (NICU). Various strategies to reduce errors have been described in adult and paediatric patients but there are few published data on their effect in the NICU.
To describe the medication errors occurring within an NICU, and assess the impact of a combined risk management/clinical pharmacist led education programme on these errors.
Medication errors were identified prospectively over one year by critical incident reporting. Four months into the study, a pharmacist led education programme was instituted. This involved a daily, cot side, pharmacist led review of medication orders. Each new member of pharmacy, nursing, or medical staff was also required to successfully complete a series of dose calculations. In addition, a risk management approach was used to make several changes in practice during the study period.
A total of 105 errors were identified, four serious, 45 potentially serious, and 56 minor. The four serious errors included two tenfold dose miscalculations. Most (71%) of the errors were due to poor prescribing. After the introduction of our interventions, monthly medication errors fell from a mean (SD) of 24.1 (1.7) per 1000 neonatal activity days to 5.1 (3.6) per 1000 days (p < 0.001) in the following three months. The subsequent change over of junior medical staff was associated with a significant increase in medication errors to 12.2 (3.6) per 1000 neonatal activity days (p = 0.037). However, the number remained significantly less than before our interventions (p < 0.001). Three serious errors occurred in the first four months compared with one in the second eight month period, the latter corresponding to the six monthly change over of junior medical staff.
Medication errors are common in NICUs. Fortunately, actual harm to an infant is rare. Interventions to reduce errors, particularly within the context of a risk management programme, are effective.
用药错误在新生儿重症监护病房(NICU)很常见。针对成人和儿科患者已描述了多种减少错误的策略,但关于这些策略在NICU中的效果,发表的数据很少。
描述NICU内发生的用药错误,并评估由风险管理/临床药师主导的联合教育计划对这些错误的影响。
通过关键事件报告对用药错误进行为期一年的前瞻性识别。研究进行四个月后,开展了由药师主导的教育计划。这包括每天在病床边由药师对用药医嘱进行审查。药房、护理或医疗团队的每位新成员还需成功完成一系列剂量计算。此外,在研究期间采用风险管理方法对实践进行了多项改进。
共识别出105例错误,其中4例严重,45例潜在严重,56例轻微。4例严重错误包括2例剂量计算错误达10倍。大多数(71%)错误是由于处方不当。在实施我们的干预措施后,接下来的三个月中,每月用药错误从每1000个新生儿活动日平均(标准差)24.1(1.7)例降至每1000天5.1(3.6)例(p<0.001)。随后初级医务人员的更替导致用药错误显著增加至每1000个新生儿活动日12.2(3.6)例(p = 0.037)。然而,该数字仍显著低于我们干预措施实施前(p<0.001)。前四个月发生了3例严重错误,而后八个月发生了1例,后者与初级医务人员每六个月的更替相对应。
用药错误在NICU中很常见。幸运的是,对婴儿造成实际伤害的情况很少见。减少错误的干预措施,尤其是在风险管理计划的背景下,效果显著。